Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer

• Status: Suspended
• Trial end date: 2023-02-01
• Target enrollment: 0
• Participant gender: Male

Summary

Phase III study that aims to evaluate the necessity of prophylactic antibiotics use after HDR brachytherapy in the treatment of prostate adenocarcinomas.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: CR-CSSS Champlain-Charles-Le Moyne
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cefazolin; Ciprofloxacin

Criteria

Inclusion Criteria:

• All patients eligible to brachytherapy for the treatment of prostate cancer

• No history of serious urinary tract infection post prostate biopsy

Exclusion Criteria:

• Urosepsis post biopsy

• Contraindication to brachytherapy